Generics

is-japan-changing-its-attitude-towards-generic-drugs

Will Japan be able to reduce its generic drug prices?

  • Japan
  • |
  • Analysis

The Japanese pharmaceutical market is the second largest pharma market in the world following on the close heels of the US. Although it records annual sales of approximately $64.5 billion (6.45 trillion Yen), only 6.6 percent of its prescription... Read more

twi-guanfacine-hydrochloride-abbreviated-new-drug-application-anda-gets-fda-approval

TWi Pharma gets FDA nod for ADHD drug


  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Taiwan-based TWi Pharmaceuticals has received tentative approval for its Abbreviated New Drug Application (ANDA)... Read more

impending-free-trade-agreement-between-gcc-and-india-will-further-open-up-the-generics-market

Gulf nations woo Indian generic firms


  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new report by investment bank Alpen Capital titled, 'The GCC pharmaceutical Outlook', a number of Gulf Cooperation... Read more

gbi-research-worldwide-statins-market-will-drop-usd19

Generics will lead to $7 bn loss for statins market

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: GBI Research has highlighted that the introduction of generic statins has kick started a decline in the global statins market... Read more

option-agreement-with-forest-laboratories-for-the-development-of-novel-mpges-1-inhibitors-and-the-us-fda-approval-for-in-licensed-molecule-crofelemer-provides-a-big-boost-to-glenmark-s-business

Glenmark generics business grows by 34%

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Glenmark Pharmaceuticals has consolidated $254.45 million for the third quarter ending December 31, 2012, marking an increase... Read more

drug-controller-general-of-india-dgci-all-generic-drug-makers-need-to-conduct-trials-and-seek-approval-within-18-months

Indian regulator cracks down on banned drugs

  • India
  • |
  • News
  • |
  • By Narayanan Suresh
  • |
  • 0 Comment

Bangalore: As a first step to prevent misuse of drugs, which have been banned abroad from being sold freely in the country, Drug Controller... Read more

dr-reddys-laboratories-drl-launched-finasteride-tablets-generic-version-of-propecia-in-the-us

Dr. Reddy's launches generic Finasteride

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Hyderabad: Dr. Reddy's Laboratories has launched Finasteride tablets (1 mg), a bioequivalent generic version of Propecia (Finasteride)... Read more

pharmascience-korea-a-korean-canadian-generics-joint-venture-is-born

Canadian generic maker enters Korea with JV

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Montreal-based generic drug developer and marketer Pharmascience is venturing into Korea by forming a joint venture (JV) with... Read more

hope-for-osteoporosis-patients-generics-of-risedronate-sodium-hydrate-by-ajinomoto-and-takeda-get-japanese-approval

Japan approves generic drug for osteoporosis

  • Japan
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Actonel 75 mg tablets and Benet 75 mg tablets, a once-monthly formulation of risedronate sodium hydrate (generic name) for the... Read more

daiichi-sankyo-espha-to-launch-five-generic-products-including-quetiapine-and-mosapride-citrate

Daiichi Sankyo generics' unit to launch 5 drugs

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Daiichi Sankyo's pharmaceuticals subsidiary, Daiichi Sankyo Espha is all set to launch five generic products Quetiapine tablets... Read more

subhanu-saxena-cipla

Cipla appoints Subhanu Saxena as CEO

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Mumbai: Indian generic pharmaceuticals company Cipla appointed Mr Subhanu Saxena as its chief executive officer. Mr Saxena comes to Cipla... Read more

Biotech-310x175_copy

US FDA extends timeline for generic drug approval

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: In a recent move, the US Food and Drug Administration (FDA) has decided to extend the timeline for granting tentative approval... Read more

Special Features

Survey Box

Chinese Bird Flu H7N9

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X